TScan Therapeutics, Inc. earnings per share and revenue

TCRX earnings per share for the last quarter are -0.25 USD whereas the estimation was -0.32 USD which accounts for 20.73% surprise. Company revenue for the same period amounts to 1.05 M USD despite the estimated figure of 1.17 M USD. Estimated earnings per share for the next quarter are -0.30 USD, and revenue is expected to reach 1.48 M USD. Also watch annual changes over time to get a bigger picture of TCRX earnings per share and revenue dynamics.